IBRX Short Pressure Intensifies
ImmunityBio, Inc. (IBRX) has officially cleared the threshold for sustained short-selling pressure, appearing on the latest FINRA Reg SHO list. The stock has maintained a short-volume ratio exceeding 50% for five consecutive trading days, a clear signal that short sellers are actively targeting the name.
Analyzing the Flow
This daily short volume flow is distinct from open interest, but its persistence on the threshold list suggests that the short-selling pressure is not merely intraday noise. It reflects a concerted effort to keep the stock under pressure. Market participants should monitor the borrow market for IBRX, as sustained threshold status often precedes increased difficulty in locating shares for shorting, which could lead to a rapid rise in borrow fees.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.